Core Viewpoint - Wanjia Group's subsidiary, Wuhua Yangke Kidney Dialysis Co., has received a notice from the Wuhua County Medical Security Management Center regarding non-compliance with medical prescription regulations, leading to a suspension of its service agreement for 61 days starting November 1, 2025 [1][2] Group 1 - Wuhua Yangke's dialysis center was found to have deviated from standard medical prescription practices, violating multiple regulations including the Prescription Management Measures and the Drug Administration Law of China [1] - The Wuhua Medical Security Management Center has mandated that the legal representative and management of Wuhua Yangke attend a meeting to address the non-compliance issues [1] - The service agreement with the Wuhua Medical Security Management Center will be suspended for 61 days, during which the dialysis center will not provide any services covered under the agreement [1][2] Group 2 - The company is taking the non-compliance issues seriously and will implement immediate corrective measures, including a comprehensive internal control review of the dialysis center's operations [2] - During the suspension period, the dialysis center will continue to operate but will only offer services outside the scope of the suspended agreement, with existing patients being redirected to nearby facilities [2] - The company believes that the limited operations during the suspension will not have a significant adverse impact on its financial condition, business, or daily operations [2]